+148.5%
MRNA vs PSKY
-5.0%
+153.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | PSKY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.6% | -0.8% | -0.4% |
| 7D | -8.2% | -6.0% | -2.3% | -4.0% |
| 30D | +125.6% | +10.7% | +114.9% | +120.5% |
| 3M | +197.1% | +1.2% | +195.9% | +200.9% |
| 6M | +148.5% | +1.5% | +147.0% | +157.5% |
| All | +148.5% | -5.0% | +153.4% | +157.5% |
Cumulative growth
Daily Returns
Daily percentage return beside PSKY.
Daily Out/Under-Performance
Portfolio return minus PSKY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSKY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded PSKY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling